The World Generic Market Report 2012Espicom Healthcare Intelligence
March 8, 2012
552 Pages - SKU: ESPI3815950
Additional InformationIndustry Issues
If the branded pharmaceutical industry was facing a patent cliff it is now teetering on the edge of it. Ironically, it is the world’s best selling drug, Lipitor, which exemplifies the trend. Despite still having patent protection, Pfizer has been unable to stem the tide of interest and pressure from a number of companies, Ranbaxy being chief amongst them. Despite pressure on prices in many markets, the generic sector continues to thrive with increased sales across the board in 2011. The maturity of the sector can also be seen in the size of the businesses: there are now 17 generic companies with revenues in excess of US$1 billion, 5 more than in 2008/09.
Consolidation and collaboration continues to be the game plan for many in the sector. The rationalisation of the industry continues, but it is driven by different motivations. Certainly Teva’s acquisition of ratiopharm was of the traditional model of adding market and value, but the 2011 acquistion of Cephalon is altogether more interesting as it supports Teva’s long term movement to the development of branded drugs. But adding capability is equally important. Watson’s acquisition of Arrow group also provided a stake in Eden Biodesign which gives the company a platform for the biosimilars market.
The generic market is experiencing two opposing trends driven by the global downturn. On one hand, the use of generics is increasing due to their cost-effectiveness and adoption has accelerated in markets where branded prescribing was dominant. On the other hand, the squeeze on government spending has not left generics untouched with many countries lowering generic prices through cuts in reimbursement rates or contract tendering with a resultant squeeze on margins.
All customers get the practical power of Espicom Interactive and at no additional cost! The interactive web-based version of The World Generic Market Report will rapidly identify the information you are looking for.
Export data and charts for inclusion in presentations
Address all questions across the product in your library
Share access with colleagues near and far with a flexible and cost-effective distribution licence. Please click on the link to contact Victoria McVeigh or telephone +44(0)1243 756027 for more details
Espicom’s Generic Drug Business Information; Espicom is the leading provider of business information on the global generic drug and emerging biosimilar markets. Throughout the year we publish a range of titles and reports which bring insight to the trends and developments which are affecting this major pharmaceutical sector. Please click on the title link below for more information.
World Generic Markets
A unique twice-monthly business publication which covers the latest company and market developments and reports on ANDA approvals, litigation, company performance and regulatory developments.
Global Biosimilars: A return to optimism? (January 2012)
Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies - and some surprising names - are positioning
themselves for market entry.
Biosimilars Business Review
Biosimilar products are entering a new phase in their development but considerable technical and regulatory hurdles remain. Biosimilars Business Review is a quarterly business intelligence service that gets under the skin of this rapidly emerging sector to probe and analyse the issues it faces.
Generic Drugs: Global collaboration opportunities (Dec 2011) This insightful report from Espicom provides a key resource for the wide assessment of 160 medium-sized generic companies operating in 35 markets worldwide. Identify merger, acquisition and partner candidates in the rapidly changing and challenged global generics market.
VOLUME I: COMPANY PROFILES
The impact of the economic downturn
Regulation & confusion in the USA
European generic opportunities
Progress with biosimilars
Prospects for growth in key markets
Extensive company profiles covering
ANDAs and launched products
M&A activity and litigation
Dr Reddy's Laboratories
Par Pharmaceutical Companies
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
VOLUME II: COUNTRY PROFILES
Country market data covering
Generic market value & 5-year forecast
SWOT analysis of each market
Patent protection/IP Issues
The manufacturing sector
More Manufacturing, Packaging & Detailing reports by Espicom Healthcare Intelligence
The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market by Espicom Healthcare Intelligence
The 20 companies examined in The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market had combined sales of more than US$17.4 billion ...
Orphan Drugs: Market Environment Products and Companies by Espicom Healthcare Intelligence
The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry’s interest in ...
The World Pharmaceutical Markets Fact Book 2012 by Espicom Healthcare Intelligence
The indispensable source of thousands of facts, figures and statistics for 66 pharmaceutical markets worldwide! In today's challenging market environment the need to understand world ...
Understanding South Korean Regional Health Markets by Espicom Healthcare IntelligenceSee all reports like this >>
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data on this fast growing ...
More Global Manufacturing, Packaging & Detailing reports
Global Packaging Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging Industry by Canadean Ltd
Global Packaging Survey 2013–2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Packaging IndustryProduct Synopsis“Global Packaging Survey 2013–2014: Market Trends, Buyer Spend ...
PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 by GlobalData
PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013SummaryGlobalData’s PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 report, ...
Global Automation and Control System Market in the Pharmaceutical and Biotech Industry by Frost & Sullivan
Global Automation and Control System Market in the Pharmaceutical and Biotech Industry - This research service identifies the major challenges in the pharmaceutical and biotech ...
Pharmaceuticals Manufacturers (Global) - Industry Report by Plimsoll Publishing Ltd.See all reports like this >>
Plimsoll Publishing’s Pharmaceuticals Manufacturers (Global) Analysis provides a detailed overview of the Pharmaceuticals Manufacturers (Global) market and delivers a comprehensive individual analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
Manufacturing, Packaging & Detailing Reports